Evidence map›Paper›PMID 30319780›Full record

ReviewNew microbes and new infections2018

Rise of antibiotic resistance in clinical enterococcal isolates during 2001-2016 in Iran: a review.

P Asadollahi, Sh Razavi, Kh Asadollahi, M R Pourshafie, M Talebi

Open access · goldAbstract readReview
In one paragraph

Review in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection of Genes Related to Linezolid Resistance (Advanced biomedical research · 2023
    Article
  4. Article
  5. Article
  6. Determination ofJournal of pathogens · 2022
    Article
  7. Article
  8. Linezolid Resistance inFrontiers in public health · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Molecular Characterization Of Vancomycin-ResistantInfection and drug resistance · 2019
    Article
  15. Prevalence of Multidrug-ResistantInfectious diseases · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

P AsadollahiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Sh RazaviDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Kh AsadollahiDepartment of Social Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
M R PourshafieDepartment of Microbiology, Pasteur Institute of Iran, Tehran, Iran.
M TalebiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Iran University of Medical Sciences · IRIlam University · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe clinical significance of enterococci is mostly related to its antibiotic resistance which contributes to colonization and infection, in particular amongst the hospitalized patients. The present review has examined the literature to provide a comprehensive data on enterococci antibiotic resistance during the last 20 years in Iran.

methodsSearch engines such as Google Scholar and PubMed were used to identify all Persian and English-language articles investigating enterococci in Iran from 1996 to 2017. The search terms were "enterococci", "enterococcal", "enterococcus", "Iran", "bacterial resistance", "antibiotic resistance" and "resistance".

resultsDecrease in the resistance trend against ampicillin, gentamycin and ciprofloxacin was observed over a period of 15 years (2001 to 2016) in Iran. During a 10 years period from 2001 to 2015, the rate of resistance among

conclusions

Indexed as

Antimicrobial resistanceclinical isolatesenterococciIranresistance trendreview

Identifiers

PMID30319780
PMCPMC6180340
OpenAlexW2891246088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.